2. DEFINITIONDEFINITION
ALGESIAALGESIA :: IT IS DEFINED AS AN ILL DEFINED,IT IS DEFINED AS AN ILL DEFINED,
UNPLEASANT SENSATION, USUALLY EVOKED BY ANUNPLEASANT SENSATION, USUALLY EVOKED BY AN
EXTERNAL OR INTERNAL NOXIOUS STIMULI.EXTERNAL OR INTERNAL NOXIOUS STIMULI.
ANALGESICANALGESIC : A DRUG THAT SELECTIVELY RELIEVES: A DRUG THAT SELECTIVELY RELIEVES
PAIN BY ACTING IN THE CNS OR PERIPHERAL PAINPAIN BY ACTING IN THE CNS OR PERIPHERAL PAIN
MECHANISM,WITHOUT SIGNIFICANTLY ALTERING THEMECHANISM,WITHOUT SIGNIFICANTLY ALTERING THE
CONCIOUSNESS.CONCIOUSNESS.
3.
4. PARACETAMOL / ACETAMINOPHEN (PANADOL)PARACETAMOL / ACETAMINOPHEN (PANADOL)
• NO ANTI INFLAMMATORY ACTIONNO ANTI INFLAMMATORY ACTION
• MODERATE ANTIPYRETICMODERATE ANTIPYRETIC
• DOES NOT CAUSE GIT IRRITATION /DOES NOT CAUSE GIT IRRITATION /
BLEEDING TIMESBLEEDING TIMES
• DOSE : 1000MG 6 HOURLYDOSE : 1000MG 6 HOURLY
5. MEFENAMIC ACID (PONSTAN)MEFENAMIC ACID (PONSTAN)
• MILD-MODERATE PAINMILD-MODERATE PAIN
• MUST BE TAKEN WITH FOODMUST BE TAKEN WITH FOOD GITGIT
UPSETUPSET
• DOSE : 250MG-500MGDOSE : 250MG-500MG
8. ETORICOXIB (ARCOXIA)ETORICOXIB (ARCOXIA)
• RAPID ONSET ANDRAPID ONSET AND
LONG-LASTINGLONG-LASTING
PAIN RELIEFPAIN RELIEF
• 120 MG MINIMUM120 MG MINIMUM
POST DENTAL OPPOST DENTAL OP
9. MORPHINEMORPHINE
• MANAGEMENT OF TERMINAL PAINMANAGEMENT OF TERMINAL PAIN
• SEVERE PAINSEVERE PAIN POST-OPPOST-OP
• DOSE : 10-20 MG 4 HOURLYDOSE : 10-20 MG 4 HOURLY
10. CODEINECODEINE
• DROWSINESS, GIT UPSETDROWSINESS, GIT UPSET
• FORMULATED WITH OTHER DRUGSFORMULATED WITH OTHER DRUGS
ASPIRIN OR ACETAMINOPHENASPIRIN OR ACETAMINOPHEN
• DOSE 30 MG OF CODEIN + 600 MGDOSE 30 MG OF CODEIN + 600 MG
OF ASPIRINOF ASPIRIN
15. REFERENCEREFERENCE
• LAURA MITCHELL, DAVID A.MITCHELL. 2010. OXFORD HANDBOOK OFLAURA MITCHELL, DAVID A.MITCHELL. 2010. OXFORD HANDBOOK OF
CLINICAL DENTISTRY. 5CLINICAL DENTISTRY. 5THTH
EDITION. 560-562EDITION. 560-562
• MALMSTROM K ET AL. 2004.MALMSTROM K ET AL. 2004. ETORICOXIB IN ACUTE PAIN ASSOCIATED WITH
DENTAL SURGERY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE
COMPARATOR-CONTROLLED DOSE-RANGING STUDY. 26(5):667-679
• PAEDIATRIC ANALGESIA GUIDELINES. JUNE 2017. ROYAL CORNWALLPAEDIATRIC ANALGESIA GUIDELINES. JUNE 2017. ROYAL CORNWALL
HOSPITALSHOSPITALS